A method for determining the content of main drug in vitamin compound powder
Through the gradient elution technology of high-performance liquid chromatography, the problem of determining the content of vitamin D3, vitamin E acetate and vitamin A palmitate in vitamin composite powder was solved, and the accurate quantity and efficient separation of each component was achieved, which improved the detection speciality and sensitivity.
Patent Information
- Application Number
- CN202411058841.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-08-02
AI Technical Summary
The prior art cannot accurately detect the content of vitamin D3, vitamin E acetate and vitamin A palmitate in vitamin complex powder at the same time, especially the isomers of previtamin D3 and vitamin D3 are difficult to separate, affecting the accurate amount of vitamin D3.
Using high performance liquid chromatography, octadecylsilane bonded silica gel chromatography column, combined with gradient elution of acetonitrile, ultrapure water and isopropanol, the detection wavelength is 265nm, the mobile phase ratio and column temperature are controlled within a specific range. , realize the effective separation and determination of previtamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate.
The accurate measurement of various components in the vitamin composite powder is achieved, which reduces the detection cost, improves the specificity and reproducibility of the detection, and ensures the transientity and sensitivity of the analysis time.
Smart Images

Figure CN118566401B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of drug analysis, and in particular, relates to a method for determining the content of a main drug in a vitamin compound powder. Background Art
[0002] Vitamin compound powder contains vitamin D3, vitamin E acetate and vitamin A palmitate. These three vitamins are often added together to various dietary supplements. Vitamin D3 can promote growth, bone calcification and healthy teeth, maintain normal levels of citrate in the blood, and prevent amino acid loss through the kidneys; vitamin A can maintain the normal functions of the skin, cornea and various mucous membranes, participate in the synthesis of rhodopsin, and enhance the photosensitivity of the retina; vitamin E has antioxidant, anti-cancer, anti-inflammatory and other biological activities, especially in scavenging free radicals in the body and blocking lipid oxidation. It can improve growth performance and enhance the body's immune ability.
[0003] At the same time, vitamin D3, vitamin E and vitamin A are all fat-soluble vitamins, among which vitamin D3 is very soluble in ethanol, acetone, chloroform and ether, slightly soluble in vegetable oil, insoluble in water, and easily converts into isomers with provitamin D3; vitamin E acetate is easily soluble in chloroform, ether, acetone and vegetable oil, soluble in alcohol, insoluble in water, has good heat resistance, can be oxidized by light, and the color becomes darker; vitamin A palmitate is sensitive to air, heat, light and humidity, insoluble in water, soluble in ethanol, and easily soluble in ether, chloroform, acetone and oils. At present, only the United States Pharmacopoeia USPNF-2024 Multivitamin and Mineral Tablets Standard mentions a method that can simultaneously detect the content of these three vitamins, but this method cannot detect the content of provitamin D3. However, provitamin D3, as an isomer that can be converted into vitamin D3, is also active, and its content needs to be calculated, otherwise it will affect the accurate quantification of vitamin D3.
[0004] Therefore, how to achieve sufficient separation of provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate, so as to achieve accurate quantification of each component in the vitamin compound powder, becomes a key issue that needs to be solved. Summary of the invention
[0005] The present invention aims to provide a method for simultaneously detecting the contents of provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate in vitamin compound powder.
[0006] The present invention provides a method for determining the content of a main drug in a vitamin compound powder, wherein the method is a high performance liquid chromatography method, wherein the high performance liquid chromatography adopts the following conditions:
[0007] Chromatographic column: chromatographic column with octadecylsilane bonded silica gel as filler,
[0008] Monitor: DAD,
[0009] Detection wavelength: 265nm,
[0010] The detection wavelength of the control solution is 265nm.
[0011] Mobile phase A: acetonitrile,
[0012] Mobile phase B: ultrapure water,
[0013] Mobile phase C: isopropanol,
[0014] Flow rate: 1.1mL / min-1.3mL / min,
[0015] Column temperature: 25℃-37℃,
[0016] The elution gradient is: first stage: the ratio of mobile phase A, B, C is (20:80:0)-(40:60:0), elution is 4min-8min, and transition to the second stage; second stage: the ratio of mobile phase A, B, C is (95:5:0)-(90:5:5), elution is 20min-25min; third stage: the ratio of mobile phase A, B, C is (78:0:22)-(82:0:18), elution is 8min-15min; fourth stage: the ratio of mobile phase A, B, C is (20:80:0)-(40:60:0), elution is 4min-8min.
[0017] The structure of the previtamin D3 is shown below:
[0018] ;
[0019] The structure of vitamin D3 is shown below:
[0020] ;
[0021] The structure of the vitamin E acetate is shown below:
[0022] ;
[0023] The structure of vitamin A palmitate is shown below:
[0024] .
[0025] It is understandable that vitamin D3 is highly active and is usually added in very small amounts in nutritional supplements. In the vitamin compound powder, the amount of vitamin D3 added is only 0.083% of vitamin E acetate. Provitamin D3 is an isomer that can be converted into vitamin D3 and is also active. Therefore, when calculating the content of vitamin D3, it needs to be calculated together with the content of provitamin D3. Usually, the peak area of provitamin D3 accounts for less than 5% of the peak area of vitamin D3, and the presence of tiny impurities in vitamin E acetate and vitamin A palmitate may interfere with the quantification of vitamin D3. Therefore, it is difficult to develop a method for simultaneously detecting the content of vitamin D3, vitamin E acetate and vitamin A palmitate in vitamin compound powder.
[0026] It can be understood that, firstly, vitamin D3 and provitamin D3 are both medium polar substances with a steroidal ring molecular structure and similar overall structures. The only differences between the two are in the hydrogen bonding force and the configuration of the conjugated system, making separation difficult. Secondly, vitamin E acetate produces a large p-π, π-π conjugated system between the benzene ring and its surrounding groups, and is greatly affected by acetonitrile, a mobile phase with a dipole effect. Thirdly, vitamin A palmitate has a large molecular weight and fewer polar groups, and is strongly retained and difficult to elute. However, using the method for determining the content of the main drug in the vitamin composite powder provided by the present invention, provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate can be separated from each other without interfering with each other, thereby achieving the determination of the content of each component.
[0027] In some embodiments, the chromatographic column is Ultimate LP-C18, and the specifications of the chromatographic column are 150 mm×4.6 mm, 5 μm.
[0028] In some embodiments, the first stage of the elution gradient is used to elute water-soluble excipient substances, the second stage of the elution gradient is used to elute previtamin D3, vitamin D3, and vitamin E acetate, the third stage of the elution gradient is used to elute vitamin A palmitate, and the mobile phase ratio of the fourth stage of the elution gradient is consistent with that of the first stage, and is used to balance the chromatographic baseline.
[0029] In some embodiments, the elution gradient is: at 0min-5min, the ratio of mobile phase A, B, and C is (20:80:0)-(40:60:0), and transitions to (95:5:0)-(90:5:5), at 5min-26min, the ratio is (95:5:0)-(90:5:5), at 27min-37min, the ratio is (78:0:22)-(82:0:18), and at 37.1min-42min, the ratio is (20:80:0)-(40:60:0).
[0030] Preferably, the elution gradient is: at 0min-5min, the ratio of mobile phase A, B, and C is 20:80:0 and transitions to 90:5:5, the ratio is 90:5:5 at 5min, the ratio is 90:5:5 at 5min-26min, the ratio is 80:0:20 at 27min-37min, and the ratio is 20:80:0 at 37.1min-42min.
[0031] In some embodiments, the flow rate is 1.2 mL / min and the column temperature is 35°C.
[0032] In some embodiments, the vitamin compound powder is provided in the form of a test solution, wherein the test solution is an isopropanol-methanol solution containing provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate, and based on each milliliter of the test solution, the concentration of provitamin D3 and vitamin D3 is 0.4-0.6 μg / mL, the concentration of vitamin E acetate is 500-700 μg / mL, and the concentration of vitamin A palmitate is 100-120 μg / mL.
[0033] In some embodiments, the test solution is prepared by breaking the aqueous wall material of the composite powder with water and then extracting it with isopropanol-methanol (1:1).
[0034] In some embodiments, the content of vitamin D3, vitamin E acetate and vitamin A palmitate is determined by the following formula:
[0035] Wherein Mr is the sample weight of the reference substance, Wr is the content of the reference substance, Ar is the peak area of the reference substance at 265nm, Vr is the dilution multiple of the reference substance, Ms is the sample weight of the test substance, As is the peak area of the test substance at 265nm, Vs is the dilution multiple of the test substance, and B is the labeled amount of vitamin D3 or vitamin E acetate or vitamin A palmitate.
[0036] When calculating the content of vitamin D3, Ar is the peak area of the reference substance at 265nm, that is, the peak area of previtamin D3 in the reference substance × 2.2 + the peak area of vitamin D3; As is the peak area of the test substance at 265nm, that is, the peak area of previtamin D3 in the test substance × 2.2 + the peak area of vitamin D3.
[0037] The method provided by the present invention can simultaneously detect the contents of provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate in vitamin compound powder, which has the advantages of low detection cost, strong specificity, good reproducibility, sensitivity and short analysis time, and realizes effective separation and content determination of each component. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 The chromatogram of vitamin D3, vitamin E acetate and vitamin A palmitate at a wavelength of 265 nm under the chromatographic conditions described in Example 1;
[0039] Figure 2 is the UV absorption curve of previtamin D3;
[0040] Figure 3 is the UV absorption curve of vitamin D3;
[0041] Figure 4 is the UV absorption curve of vitamin E acetate;
[0042] Figure 5 is the UV absorption curve of vitamin A palmitate;
[0043] Figure 6 This is a chromatogram of the vitamin compound powder reference substance solution under the mobile phase conditions described in Example 5;
[0044] Figure 7 This is a chromatogram of the vitamin compound powder test solution under the mobile phase conditions described in Example 5;
[0045] Figure 8 This is a chromatogram of a blank solution under the chromatographic conditions described in Example 8;
[0046] Fig. 9 The chromatogram of the reference substance solution under the chromatographic conditions described in Example 8;
[0047] Fig.10 The chromatogram of the test solution under the chromatographic conditions described in Example 8;
[0048] Reference numerals:
[0049] 1: Previtamin D3 peak; 2: Vitamin D3 peak; 3: Vitamin E acetate peak; 4: Vitamin A palmitate peak. DETAILED DESCRIPTION
[0050] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.
[0051] As used herein, the terms "comprises," "including," "having," "containing," or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises the listed elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
[0052] The indefinite articles "a" and "an" before the elements or components of the present invention do not limit the quantity requirements (i.e. the number of occurrences) of the elements or components. Therefore, "a" or "an" should be interpreted as including one or at least one, and the elements or components in the singular form also include the plural form, unless the quantity obviously refers to the singular form only.
[0053] In the present invention, the features defined as "first" or "second" may include one or more of the features explicitly or implicitly, and are used to distinguish and describe the features, without distinction of order or importance. In the description of the present invention, unless otherwise specified, "plurality" means two or more.
[0054] Example 1 Reproduction of the method in the prior art
[0055] In the prior art, only the United States Pharmacopoeia USP NF-2024 discloses a method for simultaneously detecting the content of vitamin D3, vitamin E, and vitamin A. This method was reproduced, and the chromatographic conditions are as follows:
[0056] Chromatographic column: XTERRA MS C18 (3.0×100mm 3.5μm),
[0057] Mobile phase A: methanol-water (90:10), containing 0.1% trifluoroacetic acid
[0058] Mobile phase B: 0.1% trifluoroacetic acid-methanol,
[0059] Detection wavelength: 325 nm for vitamin A palmitate, 265 nm for other components;
[0060] Injection volume: 50 μl,
[0061] Flow rate: 0.5mL / min,
[0062] Column temperature: 35°C,
[0063] The elution gradient is:
[0064] Time (min) A(%) B(%) 0 100 0 19 0 100 27 0 100 28 100 0 30 100 0
[0065] The obtained chromatogram is as follows Figure 1 As shown, previtamin D3 cannot be separated from the vitamin D3 peak. Since the response of previtamin D3 is greater than that of vitamin D3, when the two peaks overlap, the content calculated by combining the peak areas will be lower than the actual result, making it impossible to accurately quantify vitamin D3. Therefore, this method is not applicable.
[0066] Example 2 Selection of elution method
[0067] The use of isocratic elution may result in the risk of the substance to be tested being retained in the solvent peak. In addition, vitamin A palmitate has a large difference in molecular weight and hydrophobicity compared to other substances, making it difficult to elute using isocratic elution. Therefore, gradient elution is selected to better separate and retain the main components of different hydrophobicities.
[0068] Example 3 Selection of injection volume
[0069] Increasing the injection volume to 100 μl and increasing the injection volume can improve the detection sensitivity of vitamin D3, which accounts for the smallest proportion in the test solution.
[0070] Example 4 Screening of detection wavelength
[0071] Vitamin D3 accounts for the smallest proportion in the vitamin compound powder, so the detection wavelength selection should be conducive to the detection of vitamin D3. Comparing the UV absorption curves of each component, the characteristic absorption wavelengths of each component are shown in Table 1 below. The UV absorption curves of each component are as follows Figure 2-5 As shown by Figure 2-5 It can be seen that the maximum absorption wavelength of vitamin D3 and previtamin D3 is around 265nm, vitamin E acetate and vitamin A palmitate also respond around 265nm, and the response value changes smoothly with good durability, so 265nm is selected as the detection wavelength.
[0072] Table 1 Characteristic absorption wavelength of each component
[0073] Element Characteristic absorption wavelength (nm) Provitamin D3 262.6 Vitamin D3 266.2 Vitamin E Acetate 285.2 Vitamin A Palmitate 325.7
[0074] Example 5 Screening of mobile phase
[0075] First, after screening, it was decided to add acetonitrile and isopropanol to the system. Acetonitrile can introduce dipole effects, and isopropanol can increase hydrogen bonding and hydrophobic effects. Both reagents can increase the selectivity of the mobile phase and make the separation of each peak better. Secondly, trifluoroacetic acid can be added to the mobile phase as an anion pair reagent to enhance the retention of basic compounds, but provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate have almost no acidity or alkalinity and are neutral compounds that will not be affected by trifluoroacetic acid, so the trifluoroacetic acid added to the mobile phase of the method described in Example 1 is removed. Furthermore, increasing the proportion of water in the initial stage can quickly wash away water-soluble auxiliary materials with higher polarity, reduce interference with the components to be measured, and avoid water-soluble substances from precipitating in a high proportion of organic phase and clogging the chromatographic column. The chromatogram obtained using the mobile phase in Table 2 is shown in the following figure. Figure 6-7As shown, the components are fully separated, the peak shape is good, and the purity is qualified. Therefore, the mobile phase conditions described in Table 2 are adopted, that is, the ratio of mobile phases A, B, and C is 20:80:0 at 0min-5min, and transitions to 90:5:5, the ratio is 90:5:5 at 5min, the ratio is 90:5:5 at 5min-26min, the ratio is 80:0:20 at 27min-37min, and the ratio is 20:80:0 at 37.1min-42min.
[0076] Table 2 Mobile phase conditions
[0077] .
[0078] Example 6 Screening of test sample preparation methods
[0079] Vitamin compound powder is a granule obtained by drying the raw materials of vitamin D3, vitamin E acetate and vitamin A palmitate through a spray drying process, granulating to form an oil-in-water emulsion, and then drying. It is a fine particle that is easy to flow. Therefore, when preparing the test solution, the aqueous wall material wrapped around the composite powder must be destroyed first, so that each component is released before extraction. After the aqueous wall material is dissolved, if the polarity of the organic solvent added for extraction is too low, the wall material will precipitate from the solution to form clumps, wrapping the substance to be tested; if the polarity is too high, the substance to be tested may not be completely extracted. Comparing the following three preparation methods, method 3 is to choose to first use water to destroy the aqueous wall material of the composite powder, and then extract it with a suitable extractant.
[0080] The solution preparation method is as follows, and the results are shown in Table 3-5 below:
[0081] Preparation method 1: Accurately weigh about 0.125g of vitamin compound powder, place it in a 30mL sample bottle, add 5mL of ultrapure water, shake and sonicate until the sample is completely soaked, add 20mL of isopropanol, sonicate for 5min (shake from time to time). Take out 5mL, centrifuge at 10000rpm / min for 5min, take 1mL of the supernatant and filter it with a 0.45μm organic filter head, and take the filtrate for sampling;
[0082] Preparation method 2: Accurately weigh about 0.125g of vitamin compound powder, place it in a 30mL sample bottle, add 5mL of ultrapure water, shake and sonicate until the sample is completely soaked, add 20mL of methanol, sonicate for 5min (shake from time to time). Take out 5mL, centrifuge at 10000rpm / min for 5min, take 1mL of the supernatant and filter it with a 0.45μm organic filter head, and take the filtrate for sampling;
[0083] Preparation method 3: Accurately weigh about 0.125g of vitamin compound powder, place it in a 30mL sample bottle, add 5mL of ultrapure water, shake and sonicate until the sample is completely soaked, add 10mL of methanol and 10mL of isopropanol, and sonicate for 5min (shake from time to time). Take out 5mL, centrifuge at 10000rpm / min for 5min, take 1mL of the supernatant and filter it with a 0.45μm organic filter head, and take the filtrate for sampling.
[0084] Table 3 Relative content and standard deviation of vitamin D3 under different test solution preparation methods
[0085] ;
[0086] Table 4 Relative content and standard deviation of vitamin E acetate under different test solution preparation methods
[0087] ;
[0088] Table 5 Relative content and standard deviation of vitamin A palmitate under different test solution preparation methods
[0089] ;
[0090] Note: Relative content (%) = detected content of vitamin D3 or vitamin E acetate or vitamin A palmitate in the test sample / (test sample weight × labeled amount of vitamin D3 or vitamin E acetate or vitamin A palmitate).
[0091] It can be seen from the above table that among the three methods, the test solution prepared according to preparation method 3 has the highest content of each substance, the smallest standard deviation, and good repeatability. Therefore, preparation method 3 is selected as the preparation method for the vitamin compound powder test solution.
[0092] Example 7 Selection of calculation method for relevant substance content
[0093] The principal component external standard method was selected to calculate the content of each substance. When calculating the vitamin D3 content, since the response of previtamin D3 is different from that of vitamin D3, it is necessary to multiply the correction factor and then add it to the vitamin D3 peak area as the reference peak area. The content of vitamin D3, vitamin E acetate, and vitamin A palmitate is determined by the following formula:
[0094] Where Mr is the sample weight of the reference substance, Wr is the content of the reference substance, Ar is the peak area of the reference substance at 265nm, Vr is the dilution multiple of the reference substance, Ms is the sample weight of the test substance, As is the peak area of the test substance at 265nm, Vs is the dilution multiple of the test substance, and B is the labeled amount of vitamin D3 or vitamin E acetate or vitamin A palmitate. When calculating the content of vitamin D3, Ar is the peak area of the reference substance at 265nm, that is, the peak area of pre-vitamin D3 of the reference substance × 2.2 + the peak area of vitamin D3; As is the peak area of the test substance at 265nm, that is, the peak area of pre-vitamin D3 in the test substance × 2.2 + the peak area of vitamin D3.
[0095] Regarding the determination of the correction factor 2.2: The Chinese Pharmacopoeia states that when calculating the content of vitamin D3 by previtamin D3, it is necessary to multiply by the correction factor f2. In this application, previtamin D3 is produced by heating the vitamin D3 solution. The specific operation and calculation method are as follows:
[0096] (1) Accurately measure 100 μl of the reference solution and inject it into the liquid chromatograph for calculating the vitamin D3 correction factor f1;
[0097] (2) Accurately measure an appropriate amount of the reference stock solution and place it in a brown volumetric bottle. After nitrogen is passed through the bottle to remove air, seal it tightly and place it in a 90°C water bath for reflux. Remove the bottle and quickly cool it to room temperature. Dilute it with a diluent to the same concentration as the reference solution. Shake well and accurately measure 100 μl and inject it into the liquid chromatograph to calculate the correction factor f2 for converting previtamin D3 to vitamin D3.
[0098] Calculation formula: ,
[0099] in:
[0100] A1: average peak area of vitamin D3 in the chromatogram obtained when calculating the correction factor f1;
[0101] A2: average peak area of vitamin D3 in the chromatogram obtained when calculating the correction factor f2;
[0102] A3: average peak area of previtamin D3 in the chromatogram obtained when calculating the correction factor f2;
[0103] A4: Average peak area of previtamin D3 in the chromatogram obtained when calculating the correction factor f1;
[0104] Through several parallel experiments, the correction factor f2=2.2 was calculated.
[0105] Example 8 Confirmation of the method
[0106] 1.1 Solution preparation
[0107] (1) Mobile phase
[0108] Mobile phase A: acetonitrile;
[0109] Mobile phase B: ultrapure water;
[0110] Mobile phase C: isopropanol;
[0111] (2) Blank solution (diluent)
[0112] water-isopropanol-acetonitrile (1:2:2);
[0113] (3) Vitamin compound powder test solution
[0114] Weigh about 0.125g of vitamin compound powder accurately, place it in a 30mL sample bottle, add 5mL of ultrapure water, shake and sonicate until the sample is completely soaked, add 10mL of methanol and 10mL of isopropanol, and sonicate for 5min (shake from time to time). Take out 5mL, centrifuge at 10000rpm / min for 5min, take 1mL of the supernatant and filter it with a 0.45μm organic filter head, and take the filtrate for sampling;
[0115] (4) Reference solution
[0116] Take appropriate amounts of vitamin D3, vitamin E acetate and vitamin A palmitate reference substances, weigh them accurately, dissolve them with appropriate amount of isopropanol, and dilute them with diluent to make a solution containing 0.5 μg vitamin D3, 600 μg vitamin E acetate, and 110 μg vitamin A palmitate per 1 mL.
[0117] 1.2 Chromatographic conditions
[0118] Chromatographic column: Ultimate LP-C18, 150 mm × 4.6 mm, 5 μm,
[0119] Flow rate: 1.2mL / min,
[0120] Column temperature: 35°C,
[0121] Detection wavelength: 265nm,
[0122] Injection volume: 100µl,
[0123] Detection time: 42 minutes,
[0124] Mobile phase: Mobile phase A: acetonitrile; Mobile phase B: ultrapure water; Mobile phase C: isopropanol,
[0125] Elution method: gradient elution,
[0126] Table 6 Elution gradient
[0127] Time (min) A(%) B(%) C(%) 0 20 80 0 5 90 5 5 26 90 5 5 27 80 0 20 37 80 0 20 37.1 20 80 0 42 20 80 0
[0128] 1.3 Sampling
[0129] Take 100 μl blank solution for injection, and impurities should not interfere with the detection. The obtained chromatogram is as follows: Figure 8 As shown;
[0130] Take 100 μl of the test solution and inject it. The chromatogram obtained is as follows: Fig. 9 As shown;
[0131] Take 100 μl of the reference solution and inject it. The chromatogram is as follows: Fig.10 shown.
[0132] 1.4 Content calculation formula
[0133] Where Mr is the sample weight of the reference substance, Wr is the content of the reference substance, Ar is the peak area of the reference substance at 265nm, Vr is the dilution multiple of the reference substance, Ms is the sample weight of the test substance, As is the peak area of the test substance at 265nm, Vs is the dilution multiple of the test substance, and B is the labeled amount of vitamin D3 or vitamin E acetate or vitamin A palmitate. The labeled amount of vitamin D3 is 0.1mg / 1000mg, the labeled amount of vitamin E acetate is 120mg / 1000mg, and the labeled amount of vitamin A palmitate is 17.6mg / 1000mg.
[0134] 1.5 Content calculation results
[0135] Table 7 Content calculation results
[0136] ;
[0137] Note: Relative content (%) = detected content of vitamin D3 or vitamin E acetate or vitamin A palmitate in the test sample / (test sample weight × labeled amount of vitamin D3 or vitamin E acetate or vitamin A palmitate).
[0138] It is understandable that due to the possibility of degradation of vitamin D3, vitamin E acetate and vitamin A palmitate during storage, the actual amount of vitamin D3, vitamin E acetate and vitamin A palmitate added in the vitamin compound powder is usually higher than the labeled amount. The vitamin compound powder tested multiple times is not from the same batch, resulting in inconsistencies in the detected contents and inconsistencies in the relative contents.
[0139] The specificity and repeatability of the determined method were investigated. The blank solution did not interfere with the determination of each component, and the test sample had good repeatability. This method can be used to detect the content of the main drug in vitamin compound powder.
Claims
1. A method for determining the content of a main drug in a vitamin compound powder, characterized in that: The method is a high performance liquid chromatography method, wherein the high performance liquid chromatography adopts the following conditions: Chromatographic column: chromatographic column with octadecylsilane bonded silica gel as filler, Monitor: DAD, Detection wavelength: 265nm, The detection wavelength of the control solution is 265nm. Mobile phase A: acetonitrile, Mobile phase B: ultrapure water, Mobile phase C: isopropanol, Flow rate: 1.1mL / min-1.3mL / min, Column temperature: 25℃-37℃, The elution gradient is as follows: the first stage: the ratio of mobile phase A, B, C is (20:80:0)-(40:60:0), elution 4min-8min, and transition to the second stage; the second stage: the ratio of mobile phase A, B, C is (95:5:0)-(90:5:5), elution 20min-25min; the third stage: the ratio of mobile phase A, B, C is (78:0:22)-(82:0:18), elution 8min-15min; the fourth stage: mobile phase A, B, C The ratio is (20:80:0)-(40:60:0), and the elution time is 4min-8min; the vitamin composite powder is provided in the form of a test solution, wherein the test solution is an isopropanol-methanol solution containing provitamin D3, vitamin D3, vitamin E acetate and vitamin A palmitate, and based on each milliliter of the test solution, the concentrations of provitamin D3 and vitamin D3 are 0.4-0.6μg / mL, the concentration of vitamin E acetate is 500-700μg / mL, and the concentration of vitamin A palmitate is 100-120μg / mL; the preparation method of the test solution is to use water to break the aqueous phase wall material of the composite powder and then extract it with isopropanol-methanol at a ratio of 1:
1.
2. The method for determining the content of the main drug in the vitamin compound powder according to claim 1, characterized in that: The chromatographic column is Ultimate LP-C18, and the specification of the chromatographic column is 150 mm×4.6 mm, 5 μm.
3. The method for determining the content of the main drug in the vitamin compound powder according to claim 1, characterized in that: The first stage of the elution gradient is used to elute water-soluble auxiliary materials, the second stage of the elution gradient is used to elute provitamin D3, vitamin D3, and vitamin E acetate, the third stage of the elution gradient is used to elute vitamin A palmitate, and the mobile phase ratio of the fourth stage of the elution gradient is consistent with that of the first stage, and is used to balance the chromatographic baseline.
4. The method for determining the content of the main drug in the vitamin compound powder according to claim 1, characterized in that: The elution gradient is: at 0min-5min, the ratio of mobile phase A, B, and C is (20:80:0)-(40:60:0), and transitions to (95:5:0)-(90:5:5), at 5min-26min, the ratio is (95:5:0)-(90:5:5), at 27min-37min, the ratio is (78:0:22)-(82:0:18), and at 37.1min-42min, the ratio is (20:80:0)-(40:60:0).
5. The method for determining the content of the main drug in the vitamin compound powder according to claim 4, characterized in that: The elution gradient is: at 0min-5min, the ratio of mobile phase A, B, and C is 20:80:0 and transitions to 90:5:5, at 5min the ratio is 90:5:5, at 5min the ratio is 90:5:5, at 5min-26min the ratio is 90:5:5, at 27min-37min the ratio is 80:0:20, and at 37.1min-42min the ratio is 20:80:
0.
6. The method for determining the content of the main drug in the vitamin compound powder according to claim 1, characterized in that: The flow rate was 1.2 mL / min.
7. The method for determining the content of the main drug in the vitamin compound powder according to claim 1, characterized in that: The column temperature was 35°C.
8. The method for determining the content of the main drug in the vitamin compound powder according to claim 1, characterized in that: The content of vitamin D3, vitamin E acetate and vitamin A palmitate is determined by the following formula: Wherein Mr is the sample weight of the reference substance, Wr is the content of the reference substance, Ar is the peak area of the reference substance at 265nm, Vr is the dilution multiple of the reference substance, Ms is the sample weight of the test substance, As is the peak area of the test substance at 265nm, Vs is the dilution multiple of the test substance, and B is the labeled amount of vitamin D3 or vitamin E acetate or vitamin A palmitate.
